ArticleClinical rheumatology2025
HIPK3 hypomethylation as a potential epigenetic biomarker in rheumatic immune diseases with emphasis on rheumatoid arthritis.
Ping Jiang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it